"Goldman Sachs Secures $650M for Inaugural Life Sciences Venture Fund"
TL;DR Summary
Goldman Sachs has established its first life sciences fund, West Street Life Sciences I, with $650 million to invest in various biotech startups, including those focused on genetic medicine, cell and immunotherapies, synthetic biology, AI, diagnostics, and life science tools. This move comes despite a challenging environment for raising first-time funds in the biotech sector, which saw a significant drop in fundraising totals for new VC funds in the previous year.
Topics:business##biotechinvestment#business-and-finance#goldmansachs#lifesciencesfund#startupfunding#venturecapital
- Goldman Sachs launches $650 million fund for life science investments STAT
- Goldman Sachs closes $650M fund aimed at biotechs FierceBiotech
- Goldman Sachs Raises $650 Million for Life-Sciences Bets - WSJ The Wall Street Journal
- Goldman Sachs Closes First Life Sciences VC Fund with $650M in Equity BioSpace
- Goldman Sachs Asset Management raises $650 mln for life sciences fund Marketscreener.com
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
43%
125 → 71 words
Want the full story? Read the original article
Read on STAT